Health score, price, valuation, risk signals, and key metrics at a glance.
Strongest: Growth (20/25); weakest: Profitability (12/25).
Data-driven signals worth keeping an eye on across the last 8 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF consistently trails net income (avg -0.1x) — earnings may be inflated by non-cash items or aggressive accounting.
as of December 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.
Shares outstanding increased 12.0% — significant dilution, likely from stock compensation or capital raises.